纽福斯（上海）生物科技有限公司
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
The 3rd BIO International Convention 2022 is Approaching 2022-06-07 19:23
Neurophth Therapeutics Appoints Xiaoning Guo as Chief Medical Officer 2022-06-02 21:00
Neurophth Raised Over $60 Million USD in Series-C Financing to Advance Gene Therapies 2021-11-23 21:30
Neurophth Announces the Completion of GMP Manufacturing Facility for Gene Therapy Products According to International Standards 2021-09-27 23:00
Neurophth Closes RMB 400 Million Series B Financing 2021-02-09 21:44
Neurophth Therapeutics Further Expands Ocular Gene Therapy Expertise with Appointment of Qiutang Li, Ph.D., as Chief Scientific Officer 2021-01-27 21:00
Neurophth Therapeutics' Treatment of Leber's Hereditary Optic Neuropathy Gene Therapy NR082 was Granted Orphan Drug Designation by U.S. FDA 2020-09-25 10:37
1